Susquehanna International Group, LLP Tiziana Life Sciences LTD Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024
BUY
$0.43 - $1.01 $4,596 - $10,795
10,689 New
10,689 $9,000
Q4 2022

Feb 14, 2023
BUY
$0.56 - $0.78 $21,948 - $30,570
39,193 New
39,193 $23,000
Q1 2022

May 16, 2022
SELL
$0.62 - $1.25 $25,437 - $51,285
-41,028 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$0.89 - $1.66 $36,514 - $68,106
41,028 New
41,028 $39,000

Others Institutions Holding TLSA

# of Institutions
32
Shares Held
1.94M
Call Options Held
19.2K
Put Options Held
0
View Full List

About Tiziana Life Sciences Ltd

TLSA Quotes by TradingView
  • Ticker TLSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,273,000
  • Market Cap $95.1M
  • Description
  • Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...
More about TLSA
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email